Evidence map›Paper›PMID 32555677›Full record

ArticlePLoS pathogens2020

Viral RNA is a target for Wolbachia-mediated pathogen blocking.

Tamanash Bhattacharya, Irene L G Newton, Richard W Hardy

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 45 citations in OpenAlex.

  1. The inhibition mechanism ofFrontiers in microbiology · 2026
    Review
  2. Article
  3. Article
  4. Interaction of themBio · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. AntiviralmBio · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. The cellular lives of Wolbachia.Nature reviews. Microbiology · 2023
    Review
  13. Article
  14. Pathogens and global health · 2023
    Article
  15. iScience · 2023
    Article
  16. Review
  17. Article
  18. Transcriptional response ofThe Journal of general virology · 2022
    Article
  19. Article
  20. AApplied and environmental microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tamanash BhattacharyaDepartment of Biology, Indiana University, Bloomington, Indiana, United States of America.ORCID 0000-0002-8129-7568
Irene L G NewtonDepartment of Biology, Indiana University, Bloomington, Indiana, United States of America.ORCID 0000-0002-7118-0374
Richard W HardyDepartment of Biology, Indiana University, Bloomington, Indiana, United States of America.ORCID 0000-0001-6912-6291
Indiana University Bloomington · US

Funding

Identifying Wolbachia effectors that facilitate host infectionR01AI144430 · NIAID · TRUSTEES OF INDIANA UNIVERSITY · PI Irene Newton · 2019 to 2026
$3.0M
Epitranscriptomic Regulation of Alphavirus Replication and TransmissionR21AI153785 · NIAID · TRUSTEES OF INDIANA UNIVERSITY · PI HARDY, RICHARD W · 2020 to 2021
$422k
Determining the mechanism of Wolbachia pathogen blockingR21AI121849 · NIAID · TRUSTEES OF INDIANA UNIVERSITY · PI NEWTON, IRENE · 2017 to 2018
$420k
NIAID NIH HHS R01 AI144430NIAID NIH HHS R21 AI121849NIAID NIH HHS R21 AI153785
6 · The paper itself

Abstract

The ability of the endosymbiont Wolbachia pipientis to restrict RNA viruses is presently being leveraged to curb global transmission of arbovirus-induced diseases. Past studies have shown that virus replication is limited early in arthropod cells colonized by the bacterium, although it is unclear if this phenomenon is replicated in mosquito cells that first encounter viruses obtained through a vertebrate blood meal. Furthermore, these cellular events neither explain how Wolbachia limits dissemination of viruses between mosquito tissues, nor how it prevents transmission of infectious viruses from mosquitoes to vertebrate host. In this study, we try to address these issues using an array of mosquito cell culture models, with an additional goal being to identify a common viral target for pathogen blocking. Our results establish the viral RNA as a cellular target for Wolbachia-mediated inhibition, with the incoming viral RNA experiencing rapid turnover following internalization in cells. This early block in replication in mosquito cells initially infected by the virus thus consequently reduces the production of progeny viruses from these same cells. However, this is not the only contributor to pathogen blocking. We show that the presence of Wolbachia reduces the per-particle infectivity of progeny viruses on naïve mosquito and vertebrate cells, consequently limiting virus dissemination and transmission, respectively. Importantly, we demonstrate that this aspect of pathogen blocking is independent of any particular Wolbachia-host association and affects viruses belonging to Togaviridae and Flaviviridae families of RNA viruses. Finally, consistent with the idea of the viral RNA as a target, we find that the encapsidated virion RNA is less infectious for viruses produced from Wolbachia-colonized cells. Collectively, our findings present a common mechanism of pathogen blocking in mosquitoes that establish a link between virus inhibition in the cell to virus dissemination and transmission.

Indexed as

AedesAnimalsCell LineChlorocebus aethiopsCricetinaeDrosophila melanogasterFlavivirusRNA, ViralTogaviridaeVero CellsWolbachiaRNA, Viral

Identifiers

PMID32555677
PMCPMC7326284
OpenAlexW3035942682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.